» Articles » PMID: 35278429

Novel Efficacious MicroRNA-30c Analogs Reduce Apolipoprotein B Secretion in Human Hepatoma and Primary Hepatocyte Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2022 Mar 12
PMID 35278429
Authors
Affiliations
Soon will be listed here.
Abstract

High plasma lipid levels have been demonstrated to increase cardiovascular disease risk. Despite advances in treatments to decrease plasma lipids, additional therapeutics are still needed because many people are intolerant or nonresponsive to these therapies. We previously showed that increasing cellular levels of microRNA-30c (miR-30c) using viral vectors or liposomes reduces plasma lipids and atherosclerosis. In this study, we aimed to synthesize potent miR-30c analogs that can be delivered to hepatoma cells without the aid of viral vectors and lipid emulsions. We hypothesized that modification of the passenger strand of miR-30c would increase the stability of miR-30c and augment its delivery to liver cells. Here, we report the successful synthesis of a series of miR-30c analogs by using different chemically modified nucleosides. In these analogs, we left the active sense strand untouched so that its biological activity remained unaltered, and we modified the passenger strand of miR-30c to enhance the stability and uptake of miR-30c by hepatoma cells through phosphorothiorate linkages and the addition of GalNAc. We show that these analogs significantly reduced apolipoprotein B secretion in Huh-7 human hepatoma cells and human primary hepatocytes without affecting apolipoprotein A1 secretion and cellular lipid levels. Our results provide a proof of concept that the passenger strand of miR-30c can be modified to increase its stability and delivery to cells while retaining the potency of the sense strand. We anticipate these miR-30c analogs will be useful in the development of more efficacious analogs for the treatment of hyperlipidemias and cardiovascular diseases.

Citing Articles

The Role of Apolipoproteins in the Commonest Cancers: A Review.

Darwish N, Al-Hail M, Mohamed Y, Al Saady R, Mohsen S, Zar A Cancers (Basel). 2023; 15(23).

PMID: 38067270 PMC: 10705282. DOI: 10.3390/cancers15235565.


Synthesis of Novel MicroRNA-30c Analogs to Reduce Apolipoprotein B Secretion in Human Hepatoma Cells.

Zheng Y, Haruehanroengra P, Yadav P, Irani S, Mao S, Wang T Bio Protoc. 2023; 12(24).

PMID: 36618093 PMC: 9797360. DOI: 10.21769/BioProtoc.4574.


Apolipoproteins: New players in cancers.

He Y, Chen J, Ma Y, Chen H Front Pharmacol. 2022; 13:1051280.

PMID: 36506554 PMC: 9732396. DOI: 10.3389/fphar.2022.1051280.


Regulatory Non-Coding RNAs in Familial Hypercholesterolemia, Theranostic Applications.

Keshavarz Alikhani H, Pourhamzeh M, Seydi H, Shokoohian B, Hossein-Khannazer N, Jamshidi-Adegani F Front Cell Dev Biol. 2022; 10:894800.

PMID: 35813199 PMC: 9260315. DOI: 10.3389/fcell.2022.894800.